Yon Ho Jee
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Yon Ho Jee has a total of 214 co-authors. Here are the top co-authors by number of shared publications:
- Peter Kraft
Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health , Rockville, MD
14 shared publications - Alicia R. Martin
Analytic and Translational Genetics Unit, Massachusetts General Hospital, Boston, MA, USA
9 shared publications - Adam S. Kibel
Department of Urology, Brigham and Women’s Hospital, Harvard Medical School, Boston, MA 02115, USA
5 shared publications - Anna Plym
Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden
5 shared publications - Edward L. Giovannucci
Department of Nutrition, Harvard T.H. Chan School of Public Health, Boston, Massachusetts
5 shared publications - Fredrik Wiklund
Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden
5 shared publications
Latest Publications
- Open Access
Proteomic Signatures Capture Environmental Exposures Across Diverse Populations
Environmental exposures shape disease risk, but the generalizability of circulating protein-based readouts of exposures across diverse populations remains unknown. Using plasma proteomic profiles of 5,416 proteins in 10,043 participants from the All of Us Research Program, we evaluated associations with and composite scores of 100+ exposures, spanning adiposity, air pollution, ambient temperature, and substance use. We find that proteomic exposure signatures are largely consistent across populations and socioeconomic strata, with 2.5 protein scores captured within-region exposure variation and outperformed geographic and socioeconomic correlates, but spatial confounders remain embedded within protein-environment associations. Scores trained in UK Biobank transferred to All of Us for biologically proximal exposures, supporting cross-biobank portability. These findings establish plasma proteomics as a scalable framework for exposure measurement across diverse populations, while underscoring that responsible applications require careful consideration of biological context, social patterning, and cohort structure.
Open AccessProteomic Signatures Capture Environmental Exposures Across Diverse Populations
Environmental exposures shape disease risk, but the generalizability of circulating protein-based readouts of exposures across diverse populations remains unknown. Using plasma proteomic profiles of 5,416 proteins in 10,043 participants from the All of Us Research Program, we evaluated associations with and composite scores of 100+ exposures, spanning adiposity, air pollution, ambient temperature, and substance use. We find that proteomic exposure signatures are largely consistent across populations and socioeconomic strata, with 2.5 protein scores captured within-region exposure variation and outperformed geographic and socioeconomic correlates, but spatial confounders remain embedded within protein-environment associations. Scores trained in UK Biobank transferred to All of Us for biologically proximal exposures, supporting cross-biobank portability. These findings establish plasma proteomics as a scalable framework for exposure measurement across diverse populations, while underscoring that responsible applications require careful consideration of biological context, social patterning, and cohort structure.
- Open Access
- 10 July 2026
- Published by Springer Nature in Nature Communications
- Vol. 17 (1) , 8515
Genetic drivers of etiologic heterogeneity in thyroid cancer
Thyroid cancer is the most common endocrine malignancy, yet its biological underpinnings remain incompletely understood. Here we show that common risk alleles for thyroid cancer point to distinct biological pathways underlying disease susceptibility. We perform a multi-ancestry genome-wide association meta-analysis of thyroid cancer (16,167 cases and 2,430,374 controls), identifying 51 independent loci, including 21 not previously reported. By integrating these loci with genetic associations for 151 thyroid-cancer-related traits, we identify pleiotropic mechanistic clusters linked to thyroid function, oncogenic pathways, and mixed physiological function. Two thyroid-specific clusters, associated with thyroid stimulating hormone or thyroid growth and function, are enriched in thyroid tissues. Oncogenic clusters include DNA repair ( ATM , CHEK2 , TP53 ) and telomere maintenance ( TERT ) genes, implicating shared cancer mechanisms. Cluster-specific polygenic scores are associated with thyroid disease, cancer, and metabolic traits across ancestry groups, suggesting distinct genetic subtypes of thyroid cancer risk and supporting pleiotropy-based approaches to genetic risk stratification.
- 10 July 2026
- Published by Springer Nature in Nature Communications
- Vol. 17 (1) , 8515
Open AccessGenetic drivers of etiologic heterogeneity in thyroid cancer
Thyroid cancer is the most common endocrine malignancy, yet its biological underpinnings remain incompletely understood. Here we show that common risk alleles for thyroid cancer point to distinct biological pathways underlying disease susceptibility. We perform a multi-ancestry genome-wide association meta-analysis of thyroid cancer (16,167 cases and 2,430,374 controls), identifying 51 independent loci, including 21 not previously reported. By integrating these loci with genetic associations for 151 thyroid-cancer-related traits, we identify pleiotropic mechanistic clusters linked to thyroid function, oncogenic pathways, and mixed physiological function. Two thyroid-specific clusters, associated with thyroid stimulating hormone or thyroid growth and function, are enriched in thyroid tissues. Oncogenic clusters include DNA repair ( ATM , CHEK2 , TP53 ) and telomere maintenance ( TERT ) genes, implicating shared cancer mechanisms. Cluster-specific polygenic scores are associated with thyroid disease, cancer, and metabolic traits across ancestry groups, suggesting distinct genetic subtypes of thyroid cancer risk and supporting pleiotropy-based approaches to genetic risk stratification.
- Top Cited PapersOpen Access
- 5 February 2026
- Published by Springer Nature in Nature Genetics
- Vol. 58 (2) , 307-316
Global multi-ancestry genome-wide analyses identify genes and biological pathways associated with thyroid cancer and benign thyroid diseases
Thyroid diseases are common and highly heritable. We performed a meta-analysis of genome-wide association studies from 19 biobanks for five thyroid diseases: thyroid cancer (ThC), benign nodular goiter, Graves’ disease, lymphocytic thyroiditis and primary hypothyroidism. We analyzed genetic association data from ~2.9 million genomes and identified 313 known and 570 new independent loci linked to thyroid diseases. We discovered genetic correlations between ThC, benign nodular goiter and autoimmune thyroid diseases ( rg = 0.16–0.97). Telomere maintenance genes contributed to benign and malignant thyroid nodular disease risk, whereas cell cycle, DNA repair and damage response genes were associated with ThC. We propose a paradigm that explains genetic predisposition to benign and malignant thyroid nodules. We found polygenic risk score associations with ThC risk of structural disease recurrence, tumor size, multifocality, lymph node metastases and extranodal extension. Polygenic risk scores identified individuals with aggressive ThC in a biobank, creating an opportunity for genetically informed population screening.
- 5 February 2026
- Published by Springer Nature in Nature Genetics
- Vol. 58 (2) , 307-316
Top Cited PapersOpen AccessGlobal multi-ancestry genome-wide analyses identify genes and biological pathways associated with thyroid cancer and benign thyroid diseases
Thyroid diseases are common and highly heritable. We performed a meta-analysis of genome-wide association studies from 19 biobanks for five thyroid diseases: thyroid cancer (ThC), benign nodular goiter, Graves’ disease, lymphocytic thyroiditis and primary hypothyroidism. We analyzed genetic association data from ~2.9 million genomes and identified 313 known and 570 new independent loci linked to thyroid diseases. We discovered genetic correlations between ThC, benign nodular goiter and autoimmune thyroid diseases ( rg = 0.16–0.97). Telomere maintenance genes contributed to benign and malignant thyroid nodular disease risk, whereas cell cycle, DNA repair and damage response genes were associated with ThC. We propose a paradigm that explains genetic predisposition to benign and malignant thyroid nodules. We found polygenic risk score associations with ThC risk of structural disease recurrence, tumor size, multifocality, lymph node metastases and extranodal extension. Polygenic risk scores identified individuals with aggressive ThC in a biobank, creating an opportunity for genetically informed population screening.
- 21 January 2026
- Published by Springer Nature in Nature Genetics
- Vol. 58 (2) , 289-298
Multi-trait and multi-ancestry genetic analysis of comorbid lung diseases and traits improves genetic discovery and polygenic risk prediction
While respiratory diseases such as chronic obstructive pulmonary disease (COPD) and asthma share many risk factors, most studies investigate them in isolation and in predominantly European-ancestry populations. Here, we conducted the most powerful multi-trait and multi-ancestry genetic analysis of respiratory diseases and auxiliary traits to date, identifying 25 new loci associated with lung function in individuals of East Asian ancestry. Using these results, we developed PRSxtra (cross-trait and cross-ancestry), a multi-trait and multi-ancestry polygenic risk score (PRS) approach that leverages shared components of heritable risk via pleiotropic effects. PRSxtra significantly improved the prediction of asthma, COPD and lung cancer compared to trait- and ancestry-matched PRSs in a multi-ancestry cohort from the All of Us Research Program, especially in diverse populations. Our results present a new framework for multi-trait and multi-ancestry studies of respiratory diseases to improve genetic discovery and polygenic prediction.
- 21 January 2026
- Published by Springer Nature in Nature Genetics
- Vol. 58 (2) , 289-298
Multi-trait and multi-ancestry genetic analysis of comorbid lung diseases and traits improves genetic discovery and polygenic risk prediction
While respiratory diseases such as chronic obstructive pulmonary disease (COPD) and asthma share many risk factors, most studies investigate them in isolation and in predominantly European-ancestry populations. Here, we conducted the most powerful multi-trait and multi-ancestry genetic analysis of respiratory diseases and auxiliary traits to date, identifying 25 new loci associated with lung function in individuals of East Asian ancestry. Using these results, we developed PRSxtra (cross-trait and cross-ancestry), a multi-trait and multi-ancestry polygenic risk score (PRS) approach that leverages shared components of heritable risk via pleiotropic effects. PRSxtra significantly improved the prediction of asthma, COPD and lung cancer compared to trait- and ancestry-matched PRSs in a multi-ancestry cohort from the All of Us Research Program, especially in diverse populations. Our results present a new framework for multi-trait and multi-ancestry studies of respiratory diseases to improve genetic discovery and polygenic prediction.
- 28 November 2025
- Published by Springer Nature in Nature Reviews Genetics
- Vol. 27 (4) , 292-305
Dissecting pleiotropy to gain mechanistic insights into human disease
Pleiotropy is the phenomenon by which a genetic variant affects multiple independent traits. Human genetics studies have identified pervasive pleiotropy throughout the genome and multitrait genome-wide association studies are growing in scale, such that dissecting pleiotropy is an increasingly important step in linking disease-associated variants to specific mechanisms. Dissecting pleiotropy entails using one of several statistical approaches to define clusters of genetic associations reflecting biological processes that are distinct and shared across traits, which must then be validated with orthogonal datasets. In this Review, we outline the various approaches to pleiotropy dissection, describing exemplary applications throughout, and discuss the remaining challenges and limitations to elucidating the shared mechanisms of disease.
- 28 November 2025
- Published by Springer Nature in Nature Reviews Genetics
- Vol. 27 (4) , 292-305
Dissecting pleiotropy to gain mechanistic insights into human disease
Pleiotropy is the phenomenon by which a genetic variant affects multiple independent traits. Human genetics studies have identified pervasive pleiotropy throughout the genome and multitrait genome-wide association studies are growing in scale, such that dissecting pleiotropy is an increasingly important step in linking disease-associated variants to specific mechanisms. Dissecting pleiotropy entails using one of several statistical approaches to define clusters of genetic associations reflecting biological processes that are distinct and shared across traits, which must then be validated with orthogonal datasets. In this Review, we outline the various approaches to pleiotropy dissection, describing exemplary applications throughout, and discuss the remaining challenges and limitations to elucidating the shared mechanisms of disease.
- Open Access
- 28 May 2025
- Published by Springer Nature in Nature Communications
- Vol. 16 (1) , 1-13
Genome-wide association studies in a large Korean cohort identify quantitative trait loci for 36 traits and illuminate their genetic architectures
Genome-wide association studies (GWAS) have predominantly focused on European ancestry populations, limiting biological discoveries across diverse populations. Here we report GWAS findings from 153,950 individuals across 36 quantitative traits in the Korean Cancer Prevention Study-II (KCPS2) Biobank. We discovered 301 previously unreported genetic loci in KCPS2, including an association between thyroid-stimulating hormone and CD36. Meta-analysis with the Korean Genome and Epidemiology Study, Biobank Japan, Taiwan Biobank, and UK Biobank identified 4588 loci that were not significant in any contributing GWAS. We describe differences in genetic architectures across these East Asian and European samples. We also highlight East Asian specific associations, including a known pleiotropic missense variant in ALDH2, which fine-mapping identified as a likely causal variant for multiple traits. Our findings provide insights into the genetic architecture of complex traits in East Asian populations and highlight how broadening the population diversity of GWAS samples can aid discovery.
- 28 May 2025
- Published by Springer Nature in Nature Communications
- Vol. 16 (1) , 1-13
Open AccessGenome-wide association studies in a large Korean cohort identify quantitative trait loci for 36 traits and illuminate their genetic architectures
Genome-wide association studies (GWAS) have predominantly focused on European ancestry populations, limiting biological discoveries across diverse populations. Here we report GWAS findings from 153,950 individuals across 36 quantitative traits in the Korean Cancer Prevention Study-II (KCPS2) Biobank. We discovered 301 previously unreported genetic loci in KCPS2, including an association between thyroid-stimulating hormone and CD36. Meta-analysis with the Korean Genome and Epidemiology Study, Biobank Japan, Taiwan Biobank, and UK Biobank identified 4588 loci that were not significant in any contributing GWAS. We describe differences in genetic architectures across these East Asian and European samples. We also highlight East Asian specific associations, including a known pleiotropic missense variant in ALDH2, which fine-mapping identified as a likely causal variant for multiple traits. Our findings provide insights into the genetic architecture of complex traits in East Asian populations and highlight how broadening the population diversity of GWAS samples can aid discovery.
- Open Access
Genetic drivers of etiologic heterogeneity in thyroid cancer
Thyroid cancer is the most common endocrine malignancy, yet its biological underpinnings remain incompletely understood. We conducted a multi-ancestry genome-wide association study meta-analysis of thyroid cancer (16,167 cases and 2,430,374 controls), identifying 51 independent loci, including 21 novel signals. We analyzed the associations of thyroid cancer risk alleles with 151 other thyroid-cancer-related traits. These pleiotropic relationships reveal mechanistic clusters linked to thyroid function, oncogenic pathways, and mixed physiological function. Two thyroid-specific clusters associated with thyroid stimulating hormone, influencing thyroid growth and function and were enriched in thyroid tissues. Oncogenic clusters included DNA repair ( ATM , CHEK2 , TP53 ) and telomere maintenance ( TERT ) genes, implicating shared cancer mechanisms. Cluster-specific polygenic scores were associated with thyroid disease, cancer, and metabolic traits across ancestry groups, suggesting distinct genetic subtypes of thyroid cancer risk. These results demonstrate the utility of pleiotropy-based approaches in uncovering thyroid cancer mechanisms and advancing genetically informed risk stratification.
Open AccessGenetic drivers of etiologic heterogeneity in thyroid cancer
Thyroid cancer is the most common endocrine malignancy, yet its biological underpinnings remain incompletely understood. We conducted a multi-ancestry genome-wide association study meta-analysis of thyroid cancer (16,167 cases and 2,430,374 controls), identifying 51 independent loci, including 21 novel signals. We analyzed the associations of thyroid cancer risk alleles with 151 other thyroid-cancer-related traits. These pleiotropic relationships reveal mechanistic clusters linked to thyroid function, oncogenic pathways, and mixed physiological function. Two thyroid-specific clusters associated with thyroid stimulating hormone, influencing thyroid growth and function and were enriched in thyroid tissues. Oncogenic clusters included DNA repair ( ATM , CHEK2 , TP53 ) and telomere maintenance ( TERT ) genes, implicating shared cancer mechanisms. Cluster-specific polygenic scores were associated with thyroid disease, cancer, and metabolic traits across ancestry groups, suggesting distinct genetic subtypes of thyroid cancer risk. These results demonstrate the utility of pleiotropy-based approaches in uncovering thyroid cancer mechanisms and advancing genetically informed risk stratification.
- Open Access
Multi-trait and multi-ancestry genetic analysis of comorbid lung diseases and traits improves genetic discovery and polygenic risk prediction
While respiratory diseases such as COPD and asthma share many risk factors, most studies investigate them in insolation and in predominantly European ancestry populations. Here, we conducted the most powerful multi-trait and -ancestry genetic analysis of respiratory diseases and auxiliary traits to date. Our approach improves the power of genetic discovery across traits and ancestries, identifying 44 novel loci associated with lung function in individuals of East Asian ancestry. Using these results, we developed PRSxtra (cross TRait and Ancestry), a multi-trait and -ancestry polygenic risk score approach that leverages shared components of heritable risk via pleiotropic effects. PRSxtra significantly improved the prediction of asthma, COPD, and lung cancer compared to trait- and ancestry-matched PRS in a multi-ancestry cohort from the All of Us Research Program, especially in diverse populations. PRSxtra identified individuals in the top decile with over four-fold odds of asthma and COPD compared to the first decile. Our results present a new framework for multi-trait and -ancestry studies of respiratory diseases to improve genetic discovery and polygenic prediction.
Open AccessMulti-trait and multi-ancestry genetic analysis of comorbid lung diseases and traits improves genetic discovery and polygenic risk prediction
While respiratory diseases such as COPD and asthma share many risk factors, most studies investigate them in insolation and in predominantly European ancestry populations. Here, we conducted the most powerful multi-trait and -ancestry genetic analysis of respiratory diseases and auxiliary traits to date. Our approach improves the power of genetic discovery across traits and ancestries, identifying 44 novel loci associated with lung function in individuals of East Asian ancestry. Using these results, we developed PRSxtra (cross TRait and Ancestry), a multi-trait and -ancestry polygenic risk score approach that leverages shared components of heritable risk via pleiotropic effects. PRSxtra significantly improved the prediction of asthma, COPD, and lung cancer compared to trait- and ancestry-matched PRS in a multi-ancestry cohort from the All of Us Research Program, especially in diverse populations. PRSxtra identified individuals in the top decile with over four-fold odds of asthma and COPD compared to the first decile. Our results present a new framework for multi-trait and -ancestry studies of respiratory diseases to improve genetic discovery and polygenic prediction.
- 16 June 2024
- Published by Oxford University Press (OUP) in Human Molecular Genetics
- Vol. 33 (18) , 1584-1591
Multi-ancestry polygenic risk scores for venous thromboembolism
Venous thromboembolism (VTE) is a significant contributor to morbidity and mortality, with large disparities in incidence rates between Black and White Americans. Polygenic risk scores (PRSs) limited to variants discovered in genome-wide association studies in European-ancestry samples can identify European-ancestry individuals at high risk of VTE. However, there is limited evidence on whether high-dimensional PRS constructed using more sophisticated methods and more diverse training data can enhance the predictive ability and their utility across diverse populations. We developed PRSs for VTE using summary statistics from the International Network against Venous Thrombosis (INVENT) consortium genome-wide association studies meta-analyses of European- (71 771 cases and 1 059 740 controls) and African-ancestry samples (7482 cases and 129 975 controls). We used LDpred2 and PRS-CSx to construct ancestry-specific and multi-ancestry PRSs and evaluated their performance in an independent European- (6781 cases and 103 016 controls) and African-ancestry sample (1385 cases and 12 569 controls). Multi-ancestry PRSs with weights tuned in European-ancestry samples slightly outperformed ancestry-specific PRSs in European-ancestry test samples (e.g. the area under the receiver operating curve [AUC] was 0.609 for PRS-CSx_combinedEUR and 0.608 for PRS-CSxEUR [P = 0.00029]). Multi-ancestry PRSs with weights tuned in African-ancestry samples also outperformed ancestry-specific PRSs in African-ancestry test samples (PRS-CSxAFR: AUC = 0.58, PRS-CSx_combined AFR: AUC = 0.59), although this difference was not statistically significant (P = 0.34). The highest fifth percentile of the best-performing PRS was associated with 1.9-fold and 1.68-fold increased risk for VTE among European- and African-ancestry subjects, respectively, relative to those in the middle stratum. These findings suggest that the multi-ancestry PRS might be used to improve performance across diverse populations to identify individuals at highest risk for VTE.
- 16 June 2024
- Published by Oxford University Press (OUP) in Human Molecular Genetics
- Vol. 33 (18) , 1584-1591
Multi-ancestry polygenic risk scores for venous thromboembolism
Venous thromboembolism (VTE) is a significant contributor to morbidity and mortality, with large disparities in incidence rates between Black and White Americans. Polygenic risk scores (PRSs) limited to variants discovered in genome-wide association studies in European-ancestry samples can identify European-ancestry individuals at high risk of VTE. However, there is limited evidence on whether high-dimensional PRS constructed using more sophisticated methods and more diverse training data can enhance the predictive ability and their utility across diverse populations. We developed PRSs for VTE using summary statistics from the International Network against Venous Thrombosis (INVENT) consortium genome-wide association studies meta-analyses of European- (71 771 cases and 1 059 740 controls) and African-ancestry samples (7482 cases and 129 975 controls). We used LDpred2 and PRS-CSx to construct ancestry-specific and multi-ancestry PRSs and evaluated their performance in an independent European- (6781 cases and 103 016 controls) and African-ancestry sample (1385 cases and 12 569 controls). Multi-ancestry PRSs with weights tuned in European-ancestry samples slightly outperformed ancestry-specific PRSs in European-ancestry test samples (e.g. the area under the receiver operating curve [AUC] was 0.609 for PRS-CSx_combinedEUR and 0.608 for PRS-CSxEUR [P = 0.00029]). Multi-ancestry PRSs with weights tuned in African-ancestry samples also outperformed ancestry-specific PRSs in African-ancestry test samples (PRS-CSxAFR: AUC = 0.58, PRS-CSx_combined AFR: AUC = 0.59), although this difference was not statistically significant (P = 0.34). The highest fifth percentile of the best-performing PRS was associated with 1.9-fold and 1.68-fold increased risk for VTE among European- and African-ancestry subjects, respectively, relative to those in the middle stratum. These findings suggest that the multi-ancestry PRS might be used to improve performance across diverse populations to identify individuals at highest risk for VTE.
- Open Access
Genome-wide association studies in a large Korean cohort identify novel quantitative trait loci for 36 traits and illuminate their genetic architectures
Genome-wide association studies (GWAS) have been predominantly conducted in populations of European ancestry, limiting opportunities for biological discovery in diverse populations. We report GWAS findings from 153,950 individuals across 36 quantitative traits in the Korean Cancer Prevention Study-II (KCPS2) Biobank. We discovered 616 novel genetic loci in KCPS2, including an association between thyroid-stimulating hormone and CD36. Meta-analysis with the Korean Genome and Epidemiology Study, Biobank Japan, Taiwan Biobank, and UK Biobank identified 3,524 loci that were not significant in any contributing GWAS. We describe differences in genetic architectures across these East Asian and European samples. We also highlight East Asian specific associations, including a known pleiotropic missense variant in ALDH2, which fine-mapping identified as a likely causal variant for a diverse set of traits. Our findings provide insights into the genetic architecture of complex traits in East Asian populations and highlight how broadening the population diversity of GWAS samples can aid discovery.
Open AccessGenome-wide association studies in a large Korean cohort identify novel quantitative trait loci for 36 traits and illuminate their genetic architectures
Genome-wide association studies (GWAS) have been predominantly conducted in populations of European ancestry, limiting opportunities for biological discovery in diverse populations. We report GWAS findings from 153,950 individuals across 36 quantitative traits in the Korean Cancer Prevention Study-II (KCPS2) Biobank. We discovered 616 novel genetic loci in KCPS2, including an association between thyroid-stimulating hormone and CD36. Meta-analysis with the Korean Genome and Epidemiology Study, Biobank Japan, Taiwan Biobank, and UK Biobank identified 3,524 loci that were not significant in any contributing GWAS. We describe differences in genetic architectures across these East Asian and European samples. We also highlight East Asian specific associations, including a known pleiotropic missense variant in ALDH2, which fine-mapping identified as a likely causal variant for a diverse set of traits. Our findings provide insights into the genetic architecture of complex traits in East Asian populations and highlight how broadening the population diversity of GWAS samples can aid discovery.